Hiv point-of-care diagnostics: Meeting the special needs of sub-Saharan Africa

Journal of Infection in Developing Countries

Volumn 8, Issue 10, 2014, Pages 1231-1243

  Aleku, Godwin A ^a,b   Adoga, Moses P ^a,c   Agwale, Simon M ^d,e  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b National Agency for Food and Drug Administration and Control Abuja   (Nigeria)

^c NASARAWA STATE UNIVERSITY   (Nigeria)

^d Innovative Biotech   (Nigeria)

^e Innovative Biotech USA Inc   (United States)

Author keywords

Diagnostics; Point of care; Resource limited settings; Sub Saharan Africa

Indexed keywords

CD4 LYMPHOCYTE COUNT; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROSCOPY; MOLECULAR DIAGNOSTICS; PERFORMANCE; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; REVIEW; VIRUS LOAD; AFRICA SOUTH OF THE SAHARA; DIAGNOSTIC TEST; HIV INFECTIONS; HOSPITAL INFORMATION SYSTEM; PROCEDURES; TRENDS;

AFRICA SOUTH OF THE SAHARA; DIAGNOSTIC TESTS, ROUTINE; HIV INFECTIONS; HUMANS; POINT-OF-CARE SYSTEMS;

EID: 84907984267     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.4664     Document Type: Review

References (80)

1. UNAIDS (2013) UNAIDS Report on Global AIDS Epidemics 2013. Available: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf. Accessed 15 December 2013
2. United Nations (2009) The Millenium Development Goals Report 2009. Available: http://www.un.org/millenniumgoals/pdf/MDG_Report_2009_ENG.pdf. Accessed 20 November 2013
3. Harries AD, Jensen PM, Zachariah R, Rusen ID, Enarson DA (2009) How Health systems in Sub-Saharan Africa can benefit from Tuberculosis and other infectious disease programmes (Unresolved issues). Int J Tuberc Lung Dis 13: 1194-1199
4. Bélec L, Bonn J (2011) Challenges in Implementing HIV Laboratory Monitoring in Resource-constrained Settings: How to do more with less Future. Microbiol 6: 1251-1260
5. Naicker S, Plange-Rhule J, Tutt RC, Eastwood JB (2009) Shortage of Healthcare Workers in developing countries--Africa. Ethn Dis 19: 60-64
6. World Health Organization (2003) Treating 3 million by 2005: making it happen: the WHO strategy. Available: http://libdoc.who.int/publications/2003/9241591129.pdf. Accessed 15 December 2013
7. World Health Organization (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Available: http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html. Accessed 18 December 2013
8. Rosen S, Fox MP (2011) Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: a Systematic Review. PLoS Med: e1001056
9. Zachariah R, Reid SD, Chaillet P, Massaquoi M, Schouten EJ, Harries AD (2011) Viewpoint: Why do we need a point-of-care CD4 test for low-income countries? Trop Med Int Health 16: 37-41
10. Libamba E, Makombe SD, Harries AD, Schouten EJ, Yu JK, Pasulani O, Mhango E, Aberle-Grasse J, Hochgesang M, Limbambala E, Lungu D (2007) Malawi's contribution to "3 by 5": achievements and challenges. Bull World Health Organ 85: 156-160
11. Wu G, Zaman MH (2012) Low-cost tools for diagnosing and monitoring HIV infection in low-resource settings. Bull World Health Organ 90: 914-920
12. Pai PN, Pai M (2012) Point-of-Care Diagnostics for HIV and Tuberculosis: Landscape, Pipeline, and Unmet Needs. Discov Med 13: 35-45
13. Spacek LA, Lutwama F, Shihab HM, Summerton J, Kamya MR, Ronald A, Laeyendecker O, Quinn TC, Mayanja-Kizza H (2011) Diagnostic accuracy of ultrasensitive heat-denatured HIV-1 p24 antigen in non-B subtypes in Kampala, Uganda. Int J STD AIDS 22: 310-314
14. Crump JA, Scott LE, Msuya E, Morrissey AB, Venter WF, Stevens WS (2009) Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa. J Virol Methods 162: 218-222
15. Murtagh MM (2012) HIV/AIDS diagnostics Technology Landscape. UNITAID. Available: http://www.unitaid.eu/images/marketdynamics/publications/UNITAID_2012_Semi-annual_Update_HIV_Diagnostics_Technology_Landscape.pdf. Accessed 22 December 2013
16. Delaney KP, Branson BM, Uniyal A, Phillips S, Candal D, Owen SM, Kerndt PR (2011) Evaluation of the performance characteristics of 6 rapid HIV antibody tests. Clin Infect Dis 52: 257-263
17. Klarkowski DB, Wazome JM, Lokuge KM, Shanks L, Mills CF, O'Brien DP (2009) The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS ONE 4: e4351
18. Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, Makombe SD, Chunda T, Squire SB, French N, Mwapasa V, Corbett EL (2011) The Uptake and Accuracy of Oral Kits for HIV Self-Testing in High HIV Prevalence Setting: A Cross-Sectional Feasibility Study in Blantyre, Malawi. PLoS Med 8: e1001102
19. Pai NP, Barick R, Tulsky JP, Shivkumar PV, Cohan D, Kalantri S, Pai M, Klein MB, Chhabra S (2008) Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. PLoS Med 5: e92
20. Pilcher CD, Louie B, Facente S, Keating S, Hackett J Jr, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW (2013) Performance of Rapid Point-of-Care and Laboratory Tests for Acute and Established HIV Infection in San Francisco. PLoS One 8: e80629
21. Luo W, Masciotra S, Delaney KP, Charurat M, Croxton T, Constantine N, Blattner W, Wesolowski L, Owen SM (2013) Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort. J Clin Virol 58 Suppl 1: e113-118
22. World Health Organization (2013) Report on the First International Symposium on Self-Testing for HIV. Available: http://apps.who.int/iris/bitstream/10665/85267/1/9789241505628_eng.pdf. Accessed 21 December 2013
23. Estrin D, Sim I (2010) Health care delivery. Open mHealth architecture: an engine for health care innovation. Science 330: 759-760
24. Franco RA, Saag MS (2013) When to start antiretroviral therapy: as soon as possible. BMC Med 11: 147
25. Lundgren JD, Babiker AG, Gordin FM, Borges AH, James D, Neaton JD (2013) When to start antiretroviral therapy: the need for an evidence base during early HIV infection. BMC Med 11: 1741-7015
26. Faal M, Naidoo N, Glencross DK, Venter WDF, Osih R (2011) Providing Immediate CD4 Count Results at HIV Testing Improves ART Initiation. J Acquir Immune Defic Syndr 58: e54-59
27. Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha MB, Lehe JD, Pete TF (2011) Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 378: 1572-1579
28. Thiam S, Thior M, Faye B, Ndiop M, Lamine-Diouf M, Diouf MB, Diallo I, Fall FB, Ndiaye JL, Albertini A, Lee E, Jorgensen P, Gaye O, Bell D (2011) Major reduction in antimalarial drug consumption in Senegal after nationwide introduction of malaria rapid diagnostic tests. PLoS One 6: e18419
29. Boyle DS, Hawkins KR, Steele MS, Singhal M, Cheng X (2011) Emerging technologies for point-of-care CD4 T-lymphocyte counting. Trends Biotechnol 30: 45-54
30. Moon SJ, Keles HO, Ozcan A, Khademhosseini A, Hæggstrom E, Kuritzkes D, Demirci U (2009) Integrating microfluidics and lensless imaging for point-of-care testing. Biosens Bioelectron 24: 3208-3214
31. Manabe YC, Wang Y, Elbireer A, Auerbach B, Castelnuovo B (2012) Evaluation of portable point-of-care CD4 counter with high sensitivity for detecting patients eligible for antiretroviral therapy. PLOS One 7: e34319
32. Watkins NN, Hassan U, Damhorst G, Ni H, Vaid A, Rodriguez W, Bashir R (2013) Microfluidic CD4+ and CD8+ T Lymphocyte Counters for Point-of-Care HIV Diagnostics Using Whole Blood. Sci Transl Med 5: 214ra170
33. Glencross D, Coetzee L, Faal M, Masango M, Stevens W (2012) Performance evaluation of the point-of-care CD4 analyser Pima using capillary blood sampling in field tests in South Africa. J Int AIDS Soc 15: 3
34. Bergeron M, Daneau G, Ding T, Sitoe NE, Westerman LE, Stokx J, Jani IV, Coetzee LM, Scott L, Weggheleire AD, Boel L, Stevens WS, Glencross DK, Peter TF (2012) Performance of the PointCare NOW System for CD4 Counting in HIV Patients Based on Five Independent Evaluations. PLoS ONE 7: e41166
35. Sukapirom K, Onlamoon N, Thepthai C, Polsrila K, Tassaneetrithep B, Pattanapanyasat K (2011) Performance Evaluation of the Alere PIMA(TM) CD4 Test for Monitoring HIV-Infected Individuals in Resource-Constrained Setting. J Acquir Immune Defic Syndr 58: 141-147
36. Guay L (2010) Scaling up early infant diagnosis as the bridge between prevention, care, and treatment. International AIDS Society, Vienna 2010. Available: http://pag.aids2010.org/session.aspx?s=150. Accessed 22 February 2013
37. Marston M, Becquet R, Zaba B, Moulton LH, Gray G, Coovadia H, Essex M, Ekouevi D, Jackson D, Coutsoudis A, Kilewo C, Leroy V, Wiktor S, Nduati R, Msellati P, Dabis F, Newell M, Ghys PD (2011) Net survival of perinatally and postnatally infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 40: 385-396
38. Interagency Task Team (2012) Early Infant Diagnosis. Available: http://www.zero-hiv.org/wp-content/uploads/2013/03/EID-TaskTeam-background-paper.pdf. Accessed 23 December 2013
39. Wittawatmongkol O, Vanprapar N, Chearskul P, Phongsamart W, Prasitsuebsai W, Sutthent R, Chokephaibulkit K (2010) Boosted p24 antigen assay for early diagnosis of perinatal HIV infection. J Med Assoc Thai 93: 187-190
40. Boyle DS, Lehman DA, Lillis L, Peterson D, Singhal M, Armes N, Parker M, Piepenburg O, Overbaugh J (2013) Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplification. MBio 4 pii: e00135-13
41. Anoje C, Aiyenigba B, Suzuki C, Badru T, Akpoigbe K, Odo M, Odafe S, Adedokun O, Torpey K, Chabikuli ON (2012) Reducing mother-to-child transmission of HIV: findings from an early infant diagnosis program in south-south region of Nigeria. BMC Public Health 12: 184
42. Aldous AL, Haubrich RH (2009) Defining treatment failure in resource-rich settings. Curr Opin HIV AIDS 4: 459-466
43. Usdin M, Guillerm M, Calmy A (2010) Patient needs and point-of-care requirements for HIV load testing in resource-limited settings. J Infect Dis 201 Suppl 1: S73-S77
44. Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker L, Wood R (2007) Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited. Antivir Ther 12: 83-88
45. Keiser O, Chi B H, Gsponer T, Boulle A, Orrell C, Phiri S, Maxwell N, Maskew M, Prozesky H, Fox MP, Westfall A, Egger M (2011) Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in Southern Africa. AIDS 25: 1761-1769
46. Kankor R, Diero L, DeLong A, Kamle L, Muyonga S, Mambo F, Walumbe E, Emonyi W, Chan P, Carter EJ, Hogan J, Buziba N (2009) Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Clin Infect Dis 49: 454-462
47. Stevens WS, Scott LE, Crowe SM (2010) Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. J Infect Dis 201: 16-26
48. Wang S, Xu F, Demirci U (2010) Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol Adv 28: 770-781
49. Puren A, Gerlach JL, Weigl BH, Kelso DM, Domingo GJ (2010) Laboratory operations, specimen processing, and handling for viral load Testing and surveillance. J Infect Dis 201: 27-36
50. Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers R, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing A, Reiss P, van Sighem AI, Nelson M, Emery S, Montaner JS, Lane HC, Larder BA (2014) An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes. J Antimicrob Chemother 69: 1104-1110
51. Stadeli KM, Richman DD (2013) Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antivir Ther 18: 115-123
52. Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, Bertagnolio S (2012) Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet 380: 1250-1258
53. Charpentier C, Talla F, Nguepi E, Si-Mohamed A, Bélec L (2010) Virological failure and HIV-1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon. AIDS Res Hum Retroviruses 27: 221-230
54. Kozal MJ (2013) Overview of HIV drug resistance testing assays. In Hirsch MS and Mitty J, editors. UpToDate. Available: http://www.uptodate.com/contents/overview-of-hiv-drug-resistance-testing-assays. Accessed 22 December 2013
55. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W (2001) Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 286: 2270-2279
56. Valenti WM (2007) Companion Diagnostic Tests in HIV Medicine: The Road to Personalized Medicine. AIDS Read 17: 546-549
57. Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT (2002) Association between presence of HLA-B* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-I reverse transcriptase inhibitor abacavir. Lancet 359: 727-773
58. Poveda E, Briz V, Quinones-Mateu M, Soriano V (2006) HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors. AIDS 20: 1359-1367
59. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908
60. Lawn SD, Wood R (2011) Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 204 Suppl 4: S1159-S1167
61. Jarvis JN., Boulle A, Loyse A, Bicanic T, Rebe K, Williams A, Harrison TS, Meintjes G (2009) High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS 23: 1182-1183
62. World Health Organization (2013) WHO Report: Global Tuberculosis Control 2013. Available: http://www.who.int/tb/publications/global_report/en/. Accessed 18 December 2013
63. Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A (2013) Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 13: 349-361
64. Lawn SD, Wood R (2012) Point-of-care urine antigen screening tests for tuberculosis and cryptococcosis: potential for mortality reduction in antiretroviral treatment programs in Africa. Clin Infect Dis 54: 739-740
65. Dowdy DW, Steingart KR, Pai M (2011) Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 8: e1001074
66. Roy M, Chiller T (2011) Preventing deaths from cryptococcal meningitis: from bench to bedside. Expert Rev Anti Infect Ther 9: 715-717
67. Lindsley MD, Mekha N, Baggett HC, Surinthong Y, Autthateinchai R, Sawatwong P, Harris JR, Park BJ, Chiller T, Balajee SA, Poonwan N (2011) Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis 53: 321-325
68. Sweeney S, Obure CD, Maier CB, Greener R, Dehne K, Vassall A (2012) Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experience. Sex Transm Infect 88: 85-99
69. Vijayan T, Klausner JD (2013) Integrating clinical services for HIV, tuberculosis, and cryptococcal disease in the developing world: a step forward with 2 novel diagnostic tests. J Int Assoc Provid AIDS Care 12: 301-305
70. Bélec L, Bonn J (2011) Challenges in Implementing HIV Laboratory Monitoring in Resource-constrained Settings: How to Do More With Less Future. Microbiol 6: 1251-1260
71. Zazzi M (2012) Dried blood spot testing: filling the gap between antiretroviral treatment & monitoring in India. Indian J Med Res 136: 903-905
72. Snijdewind IJ, van Kampen JJ, Fraaij PL, van der Ende ME, Osterhaus AD, Gruters RA (2012) Current and future applications of dried blood spots in viral disease management. Antiviral Res 93: 309-321
73. Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF (2009) Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 14: 619-629
74. Kiyaga C, Sendagire H, Joseph E, McConnell I, Grosz J, Narayan V, Esiru G, Elyanu P, Akol Z, Kirungi W, Musinguzi J, Opio A (2013) Uganda's New National Laboratory Sample Transport System: A Successful Model for Improving Access to Diagnostic Services for Early Infant HIV Diagnosis and Other Programs. PLoS One 8: e78609
75. Palamountain KM, Baker J, Cowan EP, Essajee S, Mazzola LT, Metzler M, Schito M, Stevens WY, Young GJ, Domingo GJ (2012) Perspectives on introduction and implementation of new point-of-care diagnostic tests. J Infect Dis 205 Suppl 2: S181-S190
76. Incidence Assay Critical Path Working Group (2011) More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Med 8: e1001045
77. Govindasamy D, Van Schaik N, Kranzer K, Wood R, Mathews C (2011) Linkage to HIV Care from a Mobile Testing Unit in South Africa by Different CD4 Count Strata. J Acquir Immune Defic Syndr 58: 344-352
78. Engel N, Kenneth J, Pai M (2012) TB diagnostics in India: creating an ecosystem for innovation. Expert Rev Mol Diagn 12: 21-24
79. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M (2012) Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- And Middle-Income Countries. PLoS Med 9: e1001306
80. Fisher M (2008) Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis 21: 1-3